The global sleep disorder treatment drug market is anticipated to grow at a CAGR of around 7.9% during the forecast period 2020 to 2027 and to reach around US$ 29.1 Bn by 2027.
Market Dynamics
Increasing advancements in drug discovery, rising number of patients suffering from chronic diseases across the globe and introduction of innovative drugs are major factors expected to drive the growth of global market. According to U.S. Department of Health & Human Services Insomnia is the most common specific sleep disorder with short term issues reported by about 30% of adults and chronic insomnia by 10% and 25 Million U.S. adults have obstructive sleep apnea.
In addition, major players focus on business development through strategic acquisitions and product launches in order to attract customers and increase the profit share which is expected to boost the growth of target market.
In 2020, Koninklijke Philips N.V. a conglomerate corporation partnered with Indian Sleep Disorders Association (ISDA) in order to offer a six-month online certified course in sleep medicine. The partnership is focused on providing quality treatment for sleep disorders and the company has trained more than 500 sleep technicians and guided the launch of more than 650 sleep labs in the country till date. This is expected to help the company to enhance the business presence and increase the revenue share.
In 2019, Eisai Co., Ltd. a pharmaceutical company in collaboration with Purdue Pharma L.P. submitted an application for new drug to the U.S. Food and Drug Administration (FDA) for lemborexant. The application study is based on investigational agent for sleep-wake regulation, seeking approval for the treatment of insomnia, a sleep-wake disorder. This is expected to help the company to enhance the company profit.
In 2019, Koninklijke Philips N.V. a conglomerate corporation launched a new product Philips NightBalance, a prescription sleep position therapy device designed for patients with positional obstructive sleep apnea (OSA). This product launch is expected to help the company to increase the customer base and enhance the profit ratio.
Government is spending high on development of present healthcare infrastructure along with availability of favorable reimbursement policies are among other factors expected to support the growth of target market.
However, factors such as stringent government regulations related to product approval and side effects of drugs are expected to hamper the growth of global sleep disorder treatment drug market. In addition, lack of developed infrastructure in developing countries is expected to challenge the growth of target market.
High investment for development of innovative products and consumer’s inclination towards adoption of herbal products are factors expected to create new opportunities for players operating in the target market over the forecast period. In addition, increasing partnership and agreements between regional and international players is expected to support the growth of revenue transaction.
Segment Analysis by Region
The market in North America is expected to account for major revenue share in the target market due to increasing government spending on healthcare sector. In addition, high spending by the major players for drug discovery and introduction of novel products is expected to support the growth of target market.
Presence of large number of players operating in the country and focus on business expansion through merger and partnerships is expected to boost the target market growth.
Competitive Landscape
The global market is high highly competitive due to presence of large number of players and innovative product offerings. In addition, business expansion activities through partnerships and agreements are factors expected to further increase the competition.
Report coverage
|
Market
|
Global Sleep Disorder Treatment Drug Market
|
|
Analysis Period
|
2016 – 2027
|
|
Base Year
|
2019
|
|
Forecast Data
|
2020 – 2027
|
|
Market Stratification
|
Drug Class, Application, Distribution Channel and Geography
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Report Coverage
|
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis
|
Sleep Disorder Treatment Drug Market Segment Analysis, 2019
The global sleep disorder treatment drug market is segmented into drug class, application, and distribution channel. The sleep disorder segment is bifurcated into sedative-hypnotics, benzodiazepines, dual orexin receptor antagonists, melatonin receptor agonists, antidepressants, and others. Among the drug class the sedative-hypnotics segment is expected to account for major revenue share in the target market. The distribution channel segment is divided into retail pharmacies, online platforms, and others. Among the distribution channel, the online platform is expected to witness faster growth in the target segment.
The players profiled in the report are GlaxoSmithKline plc, Koninklijke Philips N.V., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Cardinal Health, Pfizer Inc, Sanofi, Merck & Co Inc, Becton Dickson and Company, and Natus Medical Incorporated.
Market Segmentation
Market By Drug Class
Sedative-hypnotics
Benzodiazepines
Dual orexin receptor antagonists
Melatonin receptor agonists
Antidepressants
Others
Market By Application
Intrinsic sleep disorders
- Psychophysiological insomnia
- Narcolepsy
- Restless legs syndrome
- Obstructive sleep apnea syndrome
- Others
Extrinsic sleep disorders
- Environmental sleep disorder
- Food allergy insomnia
- Toxin-induced sleep disorder
- Others
Market By Distribution Channel
Retail pharmacies
Online platforms
Others
Market By Region
North America
Europe
- UK
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
CHAPTER 1. Industry Overview of Sleep Disorders Treatment Drugs
1.1. Definition and Scope
1.1.1. Definition of Sleep Disorders Treatment Drugs
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Sleep Disorders Treatment Drugs Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Sleep Disorders Treatment Drugs Market By Drug Class
1.2.3. Sleep Disorders Treatment Drugs Market By Application
1.2.4. Sleep Disorders Treatment Drugs Market By Distribution Channel
1.2.5. Sleep Disorders Treatment Drugs Market by Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Sleep Disorders Treatment Drugs Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Sleep Disorders Treatment Drugs Market
3.7. Value Chain Analysis
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2019
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Sleep Disorders Treatment Drugs Market By Drug Class
4.1. Introduction
4.2. Sleep Disorders Treatment Drugs Revenue By Drug Class
4.2.1. Sleep Disorders Treatment Drugs Revenue (US$ Mn) and Forecast, By Drug Class, 2016-2027
4.2.2. Sedative-hypnotics
4.2.2.1. Sedative-hypnotics Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3. Benzodiazepines
4.2.3.1. Benzodiazepines Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.4. Dual orexin receptor antagonists
4.2.4.1. Dual orexin receptor antagonists Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.5. Melatonin receptor agonists
4.2.5.1. Melatonin receptor agonists Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.6. Antidepressants
4.2.6.1. Antidepressants Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.7. Others
4.2.7.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 5. Sleep Disorders Treatment Drugs Market Revenue By Application
5.1. Introduction
5.2. Sleep Disorders Treatment Drugs Revenue (US$ Mn) By Application
5.2.1. Sleep Disorders Treatment Drugs Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
5.2.2. Intrinsic sleep disorders
5.2.2.1. Intrinsic sleep disorders Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.2.2. Psychophysiological insomnia
5.2.2.3. Narcolepsy
5.2.2.4. Restless legs syndrome
5.2.2.5. Obstructive sleep apnea syndrome
5.2.2.6. Others
5.2.3. Extrinsic sleep disorders
5.2.3.1. Extrinsic sleep disorders Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3.2. Environmental sleep disorder
5.2.3.3. Food allergy insomnia
5.2.3.4. Toxin-induced sleep disorder
5.2.3.5. Others
CHAPTER 6. Sleep Disorders Treatment Drugs Market By Distribution Channel
6.1. Introduction
6.2. Sleep Disorders Treatment Drugs Revenue (US$ Mn) By Distribution Channel
6.2.1. Sleep Disorders Treatment Drugs Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
6.2.2. Retail pharmacies
6.2.2.1. Retail pharmacies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. Online platforms
6.2.3.1. Online platforms Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.4. Others
6.2.4.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 7. North America Sleep Disorders Treatment Drugs Market By Country
7.1. North America Sleep Disorders Treatment Drugs Overview
7.2. U.S.
7.2.1. U.S. Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
7.2.2. U.S. Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
7.2.3. U.S. Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
7.3. Canada
7.3.1. Canada Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
7.3.2. Canada Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
7.3.3. Canada Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
7.4. North America PEST Analysis
CHAPTER 8. Europe Sleep Disorders Treatment Drugs Market By Country
8.1. Europe Sleep Disorders Treatment Drugs Market Overview
8.2. U.K.
8.2.1. U.K. Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
8.2.2. U.K. Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.2.3. U.K. Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
8.3. Germany
8.3.1. Germany Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
8.3.2. Germany Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.3.3. Germany Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
8.4. France
8.4.1. France Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
8.4.2. France Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.4.3. France Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
8.5. Spain
8.5.1. Spain Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
8.5.2. Spain Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.5.3. Spain Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
8.6. Rest of Europe
8.6.1. Rest of Europe Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
8.6.2. Rest of Europe Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.6.3. Rest of Europe Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Sleep Disorders Treatment Drugs Market By Country
9.1. Asia Pacific Sleep Disorders Treatment Drugs Market Overview
9.2. China
9.2.1. China Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
9.2.2. China Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.2.3. China Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
9.3. Japan
9.3.1. Japan Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
9.3.2. Japan Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.3.3. Japan Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
9.4. India
9.4.1. India Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
9.4.2. India Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.4.3. India Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
9.5. Australia
9.5.1. Australia Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
9.5.2. Australia Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.5.3. Australia Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
9.6. South Korea
9.6.1. South Korea Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
9.6.2. South Korea Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.6.3. South Korea Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
9.7.2. Rest of Asia-Pacific Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.7.3. Rest of Asia-Pacific Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Sleep Disorders Treatment Drugs Market By Country
10.1. Latin America Sleep Disorders Treatment Drugs Market Overview
10.2. Brazil
10.2.1. Brazil Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
10.2.2. Brazil Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.2.3. Brazil Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
10.3. Mexico
10.3.1. Mexico Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
10.3.2. Mexico Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.3.3. Mexico Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
10.4. Rest of Latin America
10.4.1. Rest of Latin America Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
10.4.2. Rest of Latin America Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
CHAPTER 11. Middle East & Africa Sleep Disorders Treatment Drugs Market By Country
11.1. Middle East & Africa Sleep Disorders Treatment Drugs Market Overview
11.2. Saudi Arabia
11.2.1. Saudi Arabia Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
11.2.2. Saudi Arabia Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.2.3. Saudi Arabia Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
11.3. UAE
11.3.1. UAE Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
11.3.2. UAE Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.3.3. UAE Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
11.4.2. Rest of Middle East & Africa Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.4.3. Rest of Middle East & Africa Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
CHAPTER 12. Player Analysis Of Sleep Disorders Treatment Drugs
12.1. Sleep Disorders Treatment Drugs Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Sleep Disorders Treatment Drugs Market
CHAPTER 13. Company Profile
13.1. GlaxoSmithKline plc
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (US$ Mn), 2019
13.1.3.2. PSC Biotech 2019 Sleep Disorders Treatment Drugs Business Regional Distribution
13.1.4. Product/ Service and Specification
13.1.5. Recent Developments & Business Strategy
13.1.6. Manufacturing Plant Footprint Analysis
13.2. Koninklijke Philips N.V.
13.3. Takeda Pharmaceutical Company Limited
13.4. Teva Pharmaceutical Industries Ltd.
13.5. Cardinal Health
13.6. Pfizer Inc
13.7. Sanofi
13.8. Merck & Co Inc
13.9. Becton Dickson and Company
13.10. Natus Medical Incorporated
13.11. Others
![Sleep Disorder Treatment Drug Market (By Drug Class: Sedative-hypnotics, Benzodiazepines, Dual orexin receptor antagonists, Melatonin receptor agonists, Antidepressants, Others; By Application: Intrinsic sleep disorders [Psychophysiological insomnia, Narcolepsy, Restless legs syndrome, Obstructive sleep apnea syndrome, Others], Extrinsic sleep disorders [Environmental sleep disorder, Food allergy insomnia, Toxin-induced sleep disorder, Others]; By Distribution Channel: Retail pharmacies, Online platforms, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast 2020 - 2027](assets/images/format-png.png "Sleep Disorder Treatment Drug Market (By Drug Class: Sedative-hypnotics, Benzodiazepines, Dual orexin receptor antagonists, Melatonin receptor agonists, Antidepressants, Others; By Application: Intrinsic sleep disorders [Psychophysiological insomnia, Narcolepsy, Restless legs syndrome, Obstructive sleep apnea syndrome, Others], Extrinsic sleep disorders [Environmental sleep disorder, Food allergy insomnia, Toxin-induced sleep disorder, Others]; By Distribution Channel: Retail pharmacies, Online platforms, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast 2020 - 2027")
